The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials

  • Vilar, Samuel (Pain Clinic, University Hospital Virgen del Rocio) ;
  • Castillo, Jose Manuel (Department of Nursing, Physiotherapy and Podiatry, University of Seville) ;
  • Martinez, Pedro V. Munuera (Department of Nursing, Physiotherapy and Podiatry, University of Seville) ;
  • Reina, Maria (Department of Nursing, Physiotherapy and Podiatry, University of Seville) ;
  • Pabon, Manuel (Department of Nursing, Physiotherapy and Podiatry, University Hospital Cruz Roja)
  • Received : 2018.03.30
  • Accepted : 2018.06.22
  • Published : 2018.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: One of the most frequent problems caused by diabetes is the so called painful diabetic neuropathy. This condition can be treated through numerous types of therapy. The purpose of this study was to analyze, as a meta-analysis, different treatments used to alleviate painful diabetic neuropathy, with the aim of generating results that help making decisions when applying such treatments to tackle this pathology. Methods: A search was conducted in the main databases for Health Sciences, such as PUBMED, Web of Science (WOS), and IME biomedicina (Spanish Medical Reports in Biomedicine), to gather randomized controlled trials about treatments used for painful diabetic neuropathy. The analyzed studies were required to meet the inclusion criteria selected, especially those results related to pain intensity. Results: Nine randomized controlled trials were chosen. The meta-analysis shows significant positive effects for those treatments based on tapentadol [g: -1.333, 95% CI (-1.594; -1.072), P < 0.05], duloxetine [g: -1.622, 95 % CI (-1.650; -1.594), P < 0.05], pregabalin [g: -0.607, 95% CI (-0.980; -0.325), P < 0.05], and clonidine [g: -0.242, 95 % CI (-0.543; -0.058), P < 0.05]. Conclusions: This meta-analysis indicates the effectiveness of the treatments based on duloxetine, gabapentin and pregabalin, as well as other drugs, such as tapentadol and topic clonidine, whose use is better prescribed in more specific situations. The results provided can help increase the knowledge about the treatment of painful diabetic neuropathy and also in the making of clinical practice guidelines for healthcare professionals.

Keywords

References

  1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50. https://doi.org/10.1016/j.diabres.2017.03.024
  2. Asociacion Espanola de Enfermeria Vascular y Heridas (AEEVH). Guia de practica clinica: consenso sobre ulceras vasculares y pie diabetico. Segunda edicion. Seville, Asociacion Espanola de Enfermeria Vascular y Heridas. 2014. pp 1-90.
  3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-62. https://doi.org/10.2337/diacare.28.4.956
  4. Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-23, e67-e88. https://doi.org/10.1111/j.1468-1331.2010.02999.x
  5. Stein C, Eibel B, Sbruzzi G, Lago PD, Plentz RD. Electrical stimulation and electromagnetic field use in patients with diabetic neuropathy: systematic review and meta-analysis. Braz J Phys Ther 2013; 17: 93-104. https://doi.org/10.1590/S1413-35552012005000083
  6. Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 2015; 6: 432-44. https://doi.org/10.4239/wjd.v6.i3.432
  7. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American academy of neurology, the American association of neuromuscular and electrodiagnostic medicine, and the American academy of physical medicine and rehabilitation. Neurology 2011; 76: 1758-65. https://doi.org/10.1212/WNL.0b013e3182166ebe
  8. Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain 2010; 23: 99-108. https://doi.org/10.3344/kjp.2010.23.2.99
  9. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther 2009; 89: 873-80.
  10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. https://doi.org/10.1016/0197-2456(95)00134-4
  11. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. https://doi.org/10.1136/bmj.d5928
  12. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] [Internet]. London, The Cochrane Collaboration. 2011 [cited 2018 March 3]. Available at http://handbook-5-1.cochrane.org/.
  13. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-18. https://doi.org/10.1016/j.pain.2005.03.029
  14. Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth 2014; 113: 148-56. https://doi.org/10.1093/bja/aeu056
  15. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebocontrolled trial. J Pain 2005; 6: 253-60. https://doi.org/10.1016/j.jpain.2004.12.007
  16. Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012; 153: 1815-23. https://doi.org/10.1016/j.pain.2012.04.014
  17. Rauck R, Makumi CW, Schwartz S, Graff O, Meno-Tetang G, Bell CF, et al. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy. Pain Pract 2013; 13: 485-96. https://doi.org/10.1111/papr.12014
  18. Weintraub MI, Herrmann DN, Smith AG, Backonja MM, Cole SP. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil 2009; 90: 1102-9. https://doi.org/10.1016/j.apmr.2009.01.019
  19. Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebocontrolled trial. Arch Phys Med Rehabil 2003; 84: 736-46. https://doi.org/10.1016/S0003-9993(03)00106-0
  20. Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study. Clin Ther 2005; 27: 1420-31. https://doi.org/10.1016/j.clinthera.2005.09.011
  21. Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. Pain Pract 2013; 13: 497-503. https://doi.org/10.1111/papr.12013
  22. National Institute for Health and Care Excellence (NICE). Neuropathic pain in adults: the pharmacological management of neuropathic pain in adults in non-specialist settings. NICE clinical guideline. London, National Institute for Health and Care Excellence. 2013.
  23. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-73. https://doi.org/10.1016/S1474-4422(14)70251-0

Cited by

  1. Perioperative duloxetine as part of a multimodal analgesia regime reduces postoperative pain in lumbar canal stenosis surgery: a randomized, triple blind, and placebo-controlled trial vol.33, pp.1, 2020, https://doi.org/10.3344/kjp.2020.33.1.40
  2. Komplexe Behandlungsprinzipien in der orthopädischen Rheumatologie vol.16, pp.5, 2018, https://doi.org/10.1055/a-1390-9842